CD36 and cancer: CD36-mediated activation of SRC/MAPK, AKT/GSK3β/β-catenin signaling axes, STAT3, and SOX2 had been shown to induce epithelial-mesenchymal transition (EMT) and promote proliferation, cancer stemness, metastasis as well as drug resistance (7).